8-K
filed February 1, 2024, 6:59 PM ET
ticker TVGN
CIK 0001860871
M&A
confidence high
sentiment positive
materiality 0.75
Semper Paratus shareholders approve merger with Tevogen Bio; redemptions ~$15.9M
Tevogen Bio Holdings Inc.
- Shareholders approved all proposals, including business combination, domestication, and charter changes.
- Approximately 1.43M public shares redeemed for ~$15.9M (~$11.07 per share) from trust.
- Combined company expected to trade on Nasdaq as 'TVGN' after closing.
- Elected board: Dr. Curtis Patton, Jeffrey Feike, Surendra Ajjarapu, Victor Sordillo, Dr. Keow Lin Goh, Dr. Ryan Saadi, Susan Podlogar.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 4(A) — Advisory Charter Proposal to increase authorized share capital to 800,000,000 shares of common stock and 20,000,000 shares of preferred stock at the 2024-01-31 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
A proposal to increase the authorized share capital of Semper Paratus to 800,000,000 shares of common stock, par value $0.0001 per share, of New Tevogen and 20,000,000 shares of preferred stock, par value $0.0001 per share, of New Tevogen: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 3 — The Organizational Documents Proposal at the 2024-01-31 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
Proposal No. 3 — The Organizational Documents Proposal — The approval of the Organizational Documents Proposal required the affirmative vote of two-thirds (2/3) of the votes of the votes cast by holders of Semper Paratus’ ordinary shares present in person or represented by proxy and entitled to vote at the Meeting. The following is a tabulation of the votes with respect to this proposal, which was approved by Semper Paratus’ shareholders: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 2 — The Domestication Proposal at the 2024-01-31 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
Proposal No. 2 — The Domestication Proposal — The approval of the Domestication Proposal required the affirmative vote of two-thirds (2/3) of the votes of the votes cast by holders of Semper Paratus’ ordinary shares present in person or represented by proxy and entitled to vote at the Meeting. The following is a tabulation of the votes with respect to this proposal, which was approved by Semper Paratus’ shareholders: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 4(B) — Advisory Charter Proposal to provide the alteration of authorized shares of New Tevogen requires affirmative vote of majority of stock authorized to vote at the 2024-01-31 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
A proposal to provide the alteration of authorized shares of New Tevogen requires the affirmative vote of the holders of a majority New Tevogen’s stock authorized to vote: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 4(E) — Advisory Charter Proposal to eliminate the ability of stockholders to take action by written consent in lieu of a meeting at the 2024-01-31 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
A proposal to eliminate the ability of New Tevogen stockholders to take action by written consent in lieu of a meeting: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 4(C) — Advisory Charter Proposal to permit removal of a director only for cause and only by affirmative vote of at least two-thirds entitled to vote at the 2024-01-31 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
A proposal to permit removal of a director only for cause and only by the affirmative vote of the holders of at least two-thirds (2/3) entitled to vote at an election of directors of New Tevogen: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 1 — The Business Combination Proposal — Approval of the Business Combination at the 2024-01-31 meeting.
- Proposal
- merger approval
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
Proposal No. 1 — The Business Combination Proposal — The approval of the Business Combination Proposal required the affirmative vote of a majority of the votes cast by holders of Semper Paratus’ ordinary shares present in person or represented by proxy and entitled to vote at the Meeting. The following is a tabulation of the votes with respect to this proposal, which was approved by Semper Paratus’ shareholders: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tevogen Bio Holdings Inc. shareholders approved Proposal No. 4(D) — Advisory Charter Proposal to provide that the number of directors will be fixed from time to time by a majority of the board of directors at the 2024-01-31 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
A proposal to provide that, subject to the rights of holders of any series of preferred stock, the number of directors will be fixed from time to time by a majority of the board of directors of New Tevogen: For Against Abstain Broker Non-Votes 13,840,594 143,495 0 n/a
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.